AASLD Responds to Federal Court Ruling Preserving Hepatitis Vaccine
Alexandria, VA – March 18, 2026 — The American Association for the Study of Liver Diseases (AASLD) supports a recent federal...
AASLD Announces the 2026 Class of Fellows and Associate Fellows
The American Association for the Study of Liver Diseases (AASLD), the leading organization of scientists and health care...
Webinar: Isolated Core Antibodies
Moderator: Robert Gish, MD, FAASLD
Presenters: Min Kim, MD
This webinar will outline the CDC Screening and Testing for Hepatitis B...
Policy Update from AASLD President Saul J. Karpen & Hepatology Associate Representative, Dawn Drazek
AASLD recently submitted formal comments to the U.S. Department of Education opposing a proposed rule that would exclude nurse...
Save the Date: 2027 Spring Emerging Topic Conference
The 2027 Spring Emerging Topic Conference will take place at the Four Seasons Hotel Las Vegas, Feb. 19–21, 2027. Stay informed...
Strengthening Collaboration Across Hepatology: All Special Interest Groups Are Now on AASLD SIGnal
AASLD’s Special Interest Groups (SIGs) are where ideas spark, collaborations begin, and advances in hepatology move forward.
We...
WIC Webinar (Part 3): Lessons Beyond Medicine: Curating Your Career
Lessons Beyond Medicine: Curating Your Career
Overcoming Barriers to Career Fulfillment: Managing Imposter Syndrome and...
March Seminar: Polygenic basis of DILI using in vitro NAM
Presenter: Takanori Takebe, MD, PhD
Drug induced liver injury (DILI) remains one of the most challenging and unpredictable forms...
2026 AASLD Distinguished Award Nominations Now Open through April 1
AASLD invites nominations to recognize leaders advancing hepatology; recipients will be honored at The Liver Meeting® 2026
ALEX...